Hodgkin's disease terminating in acute lymphosarcoma cell leukemia. A metabolic study.
D000085:Acetates / Q000378:metabolism; D000208:Acute Disease; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002247:Carbon Isotopes; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003937:Diagnosis, Differential; D005260:Female; D005947:Glucose / Q000378:metabolism; D006689:Hodgkin Disease / Q000097:blood* / Q000150:complications / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy; D006801:Humans; D007938:Leukemia / Q000097:blood / Q000209:etiology* / Q000473:pathology; D007962:Leukocytes / Q000378:metabolism*; D008055:Lipids / Q000096:biosynthesis; D008214:Lymphocytes / Q000378:metabolism; D009000:Monocytes / Q000378:metabolism; D009363:Neoplasm Proteins / Q000096:biosynthesis; D011422:Propionates / Q000378:metabolism; D012334:RNA, Neoplasm / Q000096:biosynthesis; D013936:Thymidine / Q000378:metabolism
D000085:Acetates; D000970:Antineoplastic Agents; D002247:Carbon Isotopes; D004273:DNA, Neoplasm; D008055:Lipids; D009363:Neoplasm Proteins; D011422:Propionates; D012334:RNA, Neoplasm; D005947:Glucose; D013936:Thymidine